Improving tracking of AMR bacteria in hospitals using new genomic technique
The spread of multiple bacteria could be tracked simultaneously through sequencing method
Read More
Tag: AMR
AMR testing technology from QuantaMatrix backed by research paper in Nature
The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods
Read More
Study finds link between malaria parasites developing antimalarial drug resistance
Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022
Read More
Glox Therapeutics secures £4.3m seed funding to combat AMR
The bacteriocin development programme will first target pseudomonas aeruginosa
Read More
Sandoz opens new antibiotic and biosimilar facilities in Austria and Germany
Antimicrobial resistance is considered one of the top ten global public health threats
Read More
UK launches world’s first ‘subscription-style’ payment model for antibiotics
The scheme could give NHS patients access to new antibiotics as early as 2022
Read More
EC approves Shionogi’s new antibiotic Fetcroja
Fetcroja is the first treatment to provide coverage against all Gram-negative pathogens considered of critical priority
Read More
Could ‘tailor-made’ vaccines halve bacterial disease rates?
The findings coincide with growing alarm at the threat of antimicrobial resistance (AMR) to common medicines, after last year a UN report revealed that if left unchecked, AMR could cause as many as 10 million deaths per year by 2050.
Read More
‘Weak antibiotic pipeline’ poses threat to AMR fight
Of the 60 products in development, very few seem to show benefit over existing treatments.
Read More
Pfizer UK removes sales incentives for anti-infectives
The move comes under the firm’s commitment to fight antimicrobial resistance
Read More
UK to invest in research on evolving global health threats
Chief medical officer Professor Dame Sally Davies announced funding for two projects
Read More
AMR Centre, Shionogi team up for superbug therapy
The therapy has already produced encouraging results in pre-clinical studies and regulatory toxicology tests in preparation for first-in-human clinical trials.
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
